Three years into the pandemic, many medical experts have let their guards down and resumed some semblance of normal life, though most agree there is still a time and place for COVID-19 precautions, The Washington Post reported March 12.

A vaccine strategy involving formulation changes, an initial escalating dose, and a longer wait for booster immunization results in more-effective antibody production against HIV in rhesus monkeys, a study finds.

While we do not yet know exactly how long the MRNA booster will provide protection there is some encouraging data, according to UArizona Chief of Infectious Diseases Dr. Elizabeth Connick.

Showing high efficacy against the Delta variant, Dr. Elizabeth Connick urges people to receive COVID-19 vaccinations.

Dr. Elizabeth Connick explaines how the PreventCOVIDU study is being conducted and how the findings can serve the ultimate goal of ending the pandemic.

Dr. Elizabeth Connick, UArizona Chief of the Division of Infectious Diseases and BIO5 member, weighs in on factors such as genetics, age, and sex as contributing factors behind a person’s response to receiving the COVID-19 vaccine.

Dr. Liz Connick discusses the possible need for COVID-19 booster shots and a separate study of the Moderna vaccine examining how effective the vaccine is at preventing asymptomatic infection.

Dr. Elizabeth Connick co-leads the PreventCOVIDU program, hoping to recruit up to 700 UArizona students to participate in the trial to test if vaccinated people who are exposed to COVID-19 still shed the virus from their nose and mouth and infect others.

As vaccines for COVID-19 roll out, so do questions and concerns. Doctors all over the world including Dr. Elizabeth Connick, UArizona Chief of the Division of Infectious Diseases and BIO5 member, are saying, having two vaccines is incredible.

“It is essential to include women in research studies so that they can benefit from the results of research in the same way as men,” Dr. Connick said in an interview.